PH-001

N/A

Report date: 2024/05/08 17:40:12
NME

Base Information

Drug NamePH-001
Drug Alias NamePH001PH-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEGFR exon 20 insertion mutations inhibitorsEGFR T790M inhibitorsEGFR L858R inhibitors +[4] 
TargetsEGFR exon 20 insertion mutationsEGFR T790MEGFR L858R +[4] 
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSuzhou Puhe Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Puhe Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A